Ancora Advisors, LLC Abb Vie Inc. Transaction History

Ancora Advisors, LLC

$4.06 Billion
Q3 2024

A detailed history of Ancora Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 352,966 shares of ABBV stock, worth $61.9 Million. This represents 1.72% of its overall portfolio holdings.

Number of Shares

352,966

Previous 350,466 0.71%

Holding current value

$61.9 Million

Previous $60.1 Million 15.96%

% of portfolio

1.72%

Previous 1.61%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$163.84 - $199.33 $409,600 - $498,325	2,500 Added 0.71%	352,966 $69.7 Million
Q2 2024 Aug 14, 2024	BUY	$154.79 - $180.76 $134,202 - $156,718	867 Added 0.25%	350,466 $60.1 Million
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $3.78 Million - $4.3 Million	23,621 Added 7.25%	349,599 $63.7 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $200,758 - $226,101	-1,459 Reduced 0.45%	325,978 $50.5 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $859,250 - $994,708	6,432 Added 2.0%	327,437 $48.8 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $150,663 - $187,491	1,137 Added 0.36%	321,005 $43.2 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $813,142 - $936,454	5,623 Added 1.79%	319,868 $51 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $1.33 Million - $1.6 Million	9,638 Added 3.16%	314,245 $50.8 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $424,640 - $487,034	3,164 Added 1.05%	304,607 $40.9 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $495,432 - $629,856	-3,600 Reduced 1.18%	301,443 $46.2 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $6.15 Million - $7.63 Million	46,585 Added 18.02%	305,043 $49.5 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $8.27 Million - $10.3 Million	-62,696 Reduced 19.52%	258,458 $28 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.34 Million - $1.7 Million	12,508 Added 4.05%	321,154 $43.5 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $3.61 Million - $4.1 Million	33,927 Added 12.35%	308,646 $33.3 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $1.71 Million - $1.91 Million	16,261 Added 6.29%	274,719 $30.9 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $2.79 Million - $3.07 Million	27,255 Added 11.79%	258,458 $28 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $2.99 Million - $4.04 Million	37,163 Added 19.15%	231,203 $24.8 Million
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $1.13 Million - $1.33 Million	13,205 Added 7.3%	194,040 $17 Million
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.2 Million - $1.61 Million	16,373 Added 9.96%	180,835 $17.8 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $7.69 Million - $11.7 Million	119,162 Added 263.05%	164,462 $12.5 Million
Q4 2019 Feb 14, 2020	SELL	$72.13 - $90.25 $79,775 - $99,816	-1,106 Reduced 2.38%	45,300 $4.01 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $259,981 - $312,572	4,128 Added 9.76%	46,406 $3.51 Million
Q2 2019 Aug 12, 2019	BUY	$65.7 - $83.98 $383,950 - $490,779	5,844 Added 16.04%	42,278 $3.07 Million
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $24,916 - $29,325	323 Added 0.89%	36,434 $2.94 Million
Q4 2018 Feb 15, 2019	SELL	$77.85 - $96.01 $92,485 - $114,059	-1,188 Reduced 3.19%	36,111 $3.33 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $1,333 - $1,482	15 Added 0.04%	37,299 $3.53 Million
Q2 2018 Aug 10, 2018	SELL	$89.78 - $106.23 $1.11 Million - $1.31 Million	-12,368 Reduced 24.91%	37,284 $3.45 Million
Q1 2018 May 15, 2018	BUY	$92.01 - $123.21 $75,632 - $101,278	822 Added 1.68%	49,652 $4.7 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $12,896 - $14,142	-144 Reduced 0.29%	48,830 $4.72 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $3.42 Million - $4.37 Million	48,974	48,974 $4.35 Million

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Account

Ancora Advisors, LLC Abb Vie Inc. Transaction History